Skip to content

News Category: Health & Medical

Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib

By asianet

— Marketing authorisation in the European Economic Area anticipated in H1 2023 Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) announces today that its Marketing Authorisation Application (MAA) for leniolisib has been validated for scientific evaluation under an accelerated assessment by the European Medicines Agency’s (EMA) Committee for Medicinal Products … Continued

Cambrex to Invest 16.5 Million USD in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa

By asianet

Cambrex today announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing. Strategically located near the Minneapolis–St. Paul Airport, the new facility will specialize in analytical and chemical development for pharmaceutical drug candidates and will operate as an extension of Cambrex’s … Continued

Texas Cardiac Arrhythmia Institute physician led international workshop on cardiac arrhythmias

By asianet

The executive medical director of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center ( https://c212.net/c/link/?t=0&l=en&o=3688951-1&h=30632352&u=https%3A%2F%2Ftcainstitute.com%2F&a=Texas+Cardiac+Arrhythmia+Institute+(TCAI)+at+St.+David%27s+Medical+Center ) recently led Venice Arrhythmias ( https://c212.net/c/link/?t=0&l=en&o=3688951-1&h=3077281136&u=https%3A%2F%2Fwww.venicearrhythmias.org%2F&a=Venice+Arrhythmias ) 2022, a biennial international workshop on cardiac arrhythmias held in Venice, Italy from October 13 to October 15, 2022. As Venice Arrhythmias president, Andrea Natale, M.D., F.A.C.C., F.H.R.S., F.E.S.C., … Continued

The future you desire. The life of your dreams. See it, feel it, believe it. Get ready to receive it with LIFEBOARD VR.

By asianet

The first of its kind and totally unique – Lifeboard VR is a ground-breaking new manifestation platform to help users bring to reality their dreams and goals. It’s time to enter a fully immersive virtual reality world where you can customize your vision boards, personalize your affirmations and enjoy guided meditations. Successful leaders like Oprah, … Continued

OMRON Invests in Kirin Techno-System, Comprehensive Manufacturer of Inspection Machines

By asianet

– To Supply Safe and Secure Beverages and to Further Accelerate Global Environmental Conservation – OMRON Corporation (hereinafter “OMRON”), headquartered in Kyoto, and Kirin Brewery Company, Limited (hereinafter “Kirin Brewery”), a Tokyo-based group company of Kirin Holdings Company, Limited (hereinafter “Kirin”), also based in the Japanese capital, announced on October 18 that they have signed … Continued

FDA Accepts NMP’s Clinical Trial Application for Development of NMK89 as Imaging Agent for Cancer Diagnosis

By asianet

– Clinical Study Set to Begin, Focusing on Diagnostic Use of Theranostics – Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company in Japan, is pleased to announce that the U.S. Food and Drug Administration (FDA) has recently accepted NMP’s Investigational New Drug (IND) application to initiate a first-in-human phase I clinical study of “NMK89 … Continued

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

By asianet

Following our communication last week “MedAlliance to be acquired by Cordis”, MedAlliance is pleased to make the following announcement: Photo – https://mma.prnewswire.com/media/1928464/MedAlliance_Image.jpg Logo – https://mma.prnewswire.com/media/1196864/MedAlliance_Logo.jpg SELUTION SLR(TM), MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device Exemption (IDE) approval to initiate its coronary pivotal clinical trial. This is the first sustained limus release coronary drug … Continued

T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness

By asianet

– Preclinical data showing how ERA(TM), eTurna(TM) technologies turbocharge T-cell therapies presented at New Frontiers of RNA Nanotherapeutics meeting today – ERA(TM) boosts CAR T-cell efficacy by overcoming T-cell exhaustion that inhibits cancer cures – eTurna(TM) delivery platform delivers more healthy, functional T-cells than electroporation, without the safety risks of viral vectors – Use of … Continued

 deCODE genetics publishes multiomics study of nonalcoholic fatty liver disease

By asianet

Scientists at deCODE genetics, a subsidiary of Amgen, publish today a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Sequence variants that associate with NAFLD were identified, including rare, protective loss-of-function variants that point to potential drug targets. Plasma proteomic analyses provided further insight into the pathogenesis of  NAFLD NAFLD … Continued

SIRONA completes enrollment – A leap in the DCB treatment of femoropopliteal arterial disease

By asianet

Concept Medical Inc. [https://www.conceptmedical.com/] announces the successful completion of the SIRONA – World’s first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA [https://www.conceptmedical.com/product/magic-touch-pta/] – Concept Medical Inc.) V/S Paclitaxel DCB angioplasty for the treatment of peripheral artery disease in the femoropopliteal vessel segment. The prospective, multi-center, … Continued